205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.45%
Negative revenue growth while ADI stands at 0.26%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-33.23%
Negative gross profit growth while ADI is at 0.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
-87.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-93.30%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-80.99%
Negative net income growth while ADI stands at 3.80%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-79.07%
Negative EPS growth while ADI is at 2.08%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-79.07%
Negative diluted EPS growth while ADI is at 4.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.76%
Share reduction while ADI is at 0.28%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.28%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
9.57%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
6.27%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
21.75%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
121.43%
10Y revenue/share CAGR at 50-75% of ADI's 166.42%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
81.93%
5Y revenue/share CAGR above 1.5x ADI's 51.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
-13.17%
Negative 3Y CAGR while ADI stands at 33.53%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
367.14%
10Y OCF/share CAGR at 75-90% of ADI's 466.97%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
111.98%
5Y OCF/share CAGR above 1.5x ADI's 73.56%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
54.17%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
0.30%
Below 50% of ADI's 925.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-57.80%
Negative 5Y net income/share CAGR while ADI is 108.83%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-79.55%
Negative 3Y CAGR while ADI is 164.70%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
153.14%
10Y equity/share CAGR 1.25-1.5x ADI's 135.08%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
59.03%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-2.17%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
656.97%
Dividend/share CAGR of 656.97% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
692.36%
Dividend/share CAGR of 692.36% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
267.82%
3Y dividend/share CAGR above 1.5x ADI's 96.78%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-48.53%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-12.70%
Inventory is declining while ADI stands at 1.54%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-4.36%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-5.95%
We have a declining book value while ADI shows 0.97%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-14.99%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.18%
We cut SG&A while ADI invests at 1.54%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.